These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2240363)

  • 21. Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults.
    Sturchler D; Berger R; Rudin C; Just M; Saul A; Rzepczyk C; Brown G; Anders R; Coppel R; Woodrow G
    Am J Trop Med Hyg; 1995 Oct; 53(4):423-31. PubMed ID: 7485698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies for the development of an antimalarial vaccine.
    Enders B; Hundt E; Knapp B
    Vaccine; 1992; 10(13):920-7. PubMed ID: 1471413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against Plasmodium falciparum challenge induced in Aotus monkeys by liver-stage antigen-3-derived long synthetic peptides.
    Perlaza BL; Valencia AZ; Zapata C; Castellanos A; Sauzet JP; Blanc C; Cohen J; Arévalo-Herrera M; Corradin G; Herrera S; Druilhe P
    Eur J Immunol; 2008 Sep; 38(9):2610-5. PubMed ID: 18792413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Passive immunization of Aotus monkeys with human antibodies to the Plasmodium falciparum antigen Pf155/RESA.
    Berzins K; Perlmann H; Wåhlin B; Ekre HP; Högh B; Petersen E; Wellde B; Schoenbechler M; Williams J; Chulay J
    Infect Immun; 1991 Apr; 59(4):1500-6. PubMed ID: 2004828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.
    Patarroyo ME; Patarroyo MA
    Acc Chem Res; 2008 Mar; 41(3):377-86. PubMed ID: 18266328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria.
    Siddiqui WA; Tam LQ; Kramer KJ; Hui GS; Case SE; Yamaga KM; Chang SP; Chan EB; Kan SC
    Proc Natl Acad Sci U S A; 1987 May; 84(9):3014-8. PubMed ID: 3554251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical evaluation of a synthetic Plasmodium falciparum MAP malaria vaccine in Aotus monkeys and mice.
    Moreno CA; Rodriguez R; Oliveira GA; Ferreira V; Nussenzweig RS; Moya Castro ZR; Calvo-Calle JM; Nardin E
    Vaccine; 1999 Aug; 18(1-2):89-99. PubMed ID: 10501239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Plasmodium falciparum malaria vaccine candidate which contains epitopes from the circumsporozoite protein and a blood stage antigen, 5.1.
    Caspers P; Etlinger H; Matile H; Pink JR; Stüber D; Takács B
    Mol Biochem Parasitol; 1991 Aug; 47(2):143-50. PubMed ID: 1719416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: adjuvant effects on induction of protective immunity.
    Inselburg J; Bathurst IC; Kansopon J; Barchfeld GL; Barr PJ; Rossan RN
    Infect Immun; 1993 May; 61(5):2041-7. PubMed ID: 8478092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen.
    Jones TR; Narum DL; Gozalo AS; Aguiar J; Fuhrmann SR; Liang H; Haynes JD; Moch JK; Lucas C; Luu T; Magill AJ; Hoffman SL; Sim BK
    J Infect Dis; 2001 Jan; 183(2):303-312. PubMed ID: 11110648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coli.
    Holder AA; Freeman RR; Nicholls SC
    Parasite Immunol; 1988 Nov; 10(6):607-17. PubMed ID: 3064031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization of Aotus monkeys with recombinant cysteine-rich interdomain region 1 alpha protects against severe disease during Plasmodium falciparum reinfection.
    Makobongo MO; Keegan B; Long CA; Miller LH
    J Infect Dis; 2006 Mar; 193(5):731-40. PubMed ID: 16453270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective immunity induced in Aotus monkeys by recombinant SERA proteins of Plasmodium falciparum.
    Inselburg J; Bzik DJ; Li WB; Green KM; Kansopon J; Hahm BK; Bathurst IC; Barr PJ; Rossan RN
    Infect Immun; 1991 Apr; 59(4):1247-50. PubMed ID: 1900809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
    Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP1
    Obaldia N; Stockelman MG; Otero W; Cockrill JA; Ganeshan H; Abot EN; Zhang J; Limbach K; Charoenvit Y; Doolan DL; Tang DC; Richie TL
    Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28179404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.
    Rzepczyk CM; Csurhes PA; Lord R; Matile H
    J Immunol; 1990 Oct; 145(8):2691-6. PubMed ID: 2212657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys.
    Hisaeda H; Saul A; Reece JJ; Kennedy MC; Long CA; Miller LH; Stowers AW
    J Infect Dis; 2002 Mar; 185(5):657-64. PubMed ID: 11865423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic peptide vaccine confers protection against murine malaria.
    Zavala F; Tam JP; Barr PJ; Romero PJ; Ley V; Nussenzweig RS; Nussenzweig V
    J Exp Med; 1987 Nov; 166(5):1591-6. PubMed ID: 3316473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteosome-hydrophobic 'foot' malaria peptide vaccines for Plasmodium falciparum and P. vivax.
    Lowell GH; Ballou WR; Smith LF; Zollinger WD; Hockmeyer WT
    Trans R Soc Trop Med Hyg; 1989; 83 Suppl():101-2. PubMed ID: 2696152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity.
    Amador R; Moreno A; Valero V; Murillo L; Mora AL; Rojas M; Rocha C; Salcedo M; Guzman F; Espejo F
    Vaccine; 1992; 10(3):179-84. PubMed ID: 1557934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.